Complications of chronic necrotizing pulmonary aspergillosis: review of published case reports

Aleksandra Barac1, Tatjana Adzic Vukicevic2,3, Aleksandra Dudvarski Ilic2,3

  • 1Clinical Centre of Serbia, Clinic for Infectious and Tropic Diseases, Belgrade, Serbia.

Insights

Chronic necrotizing pulmonary aspergillosis (CNPA) can lead to serious complications. Early diagnosis and antifungal treatment are crucial for managing this fungal lung infection and improving patient outcomes.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Mycology

Background:

  • Chronic necrotizing pulmonary aspergillosis (CNPA) is a severe form of chronic pulmonary aspergillosis (CPA).
  • It primarily affects individuals with underlying lung conditions, even those with competent or mildly compromised immune systems.
  • CNPA is linked to significant morbidity and mortality, often necessitating prolonged antifungal interventions.

Purpose of the Study:

  • To review documented complications associated with CNPA.
  • To identify risk factors contributing to the development of CNPA.
  • To enhance understanding of the long-term prognosis and potential sequelae of CNPA.

Main Methods:

  • Systematic review of published literature reporting cases of CNPA complications.
  • Analysis of identified cases to highlight associated risk factors and clinical presentations.

Main Results:

  • CNPA complications include pseudomembranous necrotizing tracheobronchial aspergillosis, ankylosing spondylarthritis, pulmonary silicosis, ARDS, MAC disease, tuberculosis superinfection, and pneumothorax.
  • Diagnosis of CNPA remains challenging, often requiring bronchoscopic examination of mucus plugs and necrotic material.
  • Radiographic stability does not exclude CNPA in immunocompromised patients.

Conclusions:

  • Prompt diagnosis and treatment of Aspergillus intraluminal growth are vital.
  • Early antifungal therapy can aid in managing CNPA and preventing severe complications.
  • Further research is needed to fully elucidate the long-term prognosis and management strategies for CNPA.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
673
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K